Deutsche Bank Ag\ Fortress Biotech, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.8 - $1.5 $33,512 - $62,835	-41,890 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $5,939 - $13,172	-4,790 Reduced 10.26%	41,890 $57,000
Q4 2021 Feb 11, 2022	BUY	$2.42 - $3.65 $5,493 - $8,285	2,270 Added 5.11%	46,680 $117,000
Q3 2021 Nov 04, 2021	SELL	$2.82 - $3.7 $3,739 - $4,906	-1,326 Reduced 2.9%	44,410 $143,000
Q2 2021 Aug 11, 2021	SELL	$3.5 - $5.48 $8,302 - $12,998	-2,372 Reduced 4.93%	45,736 $163,000
Q1 2021 May 13, 2021	BUY	$3.16 - $4.89 $559 - $865	177 Added 0.37%	48,108 $169,000
Q4 2020 Feb 16, 2021	SELL	$2.2 - $4.45 $80,572 - $162,976	-36,624 Reduced 43.31%	47,931 $152,000
Q3 2020 Nov 12, 2020	BUY	$2.62 - $4.78 $143,052 - $260,988	54,600 Added 182.27%	84,555 $341,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $54,817 - $94,657	29,955 New	29,955 $81,000
Q1 2020 May 14, 2020	SELL	$1.14 - $2.96 $14,004 - $36,363	-12,285 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.25 - $2.57 $30,180 - $62,050	-24,144 Reduced 66.28%	12,285 $31,000
Q3 2019 Nov 14, 2019	BUY	$1.26 - $1.96 $34,014 - $52,912	26,996 Added 286.19%	36,429 $51,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.94 $52,745 - $71,556	-36,885 Reduced 79.63%	9,433 $13,000
Q1 2019 May 15, 2019	SELL	$0.94 - $2.47 $151,510 - $398,117	-161,181 Reduced 77.68%	46,318 $81,000
Q4 2018 Feb 14, 2019	SELL	$0.57 - $1.53 $139,068 - $373,289	-243,980 Reduced 54.04%	207,499 $177,000
Q3 2018 Dec 21, 2021	BUY	$1.44 - $3.13 $13,269 - $28,842	9,215 Added 2.08%	451,479 $722,000
Q3 2018 Nov 14, 2018	BUY	$1.44 - $3.13 $374,808 - $814,688	260,284 Added 143.03%	442,264 $706,000
Q2 2018 Apr 21, 2020	BUY	$2.92 - $5.1 $32,274 - $56,370	11,053 Added 6.47%	181,980 $542,000
Q2 2018 Aug 14, 2018	BUY	$2.92 - $5.1 $131,067 - $228,918	44,886 Added 35.61%	170,927 $508,000
Q1 2018 Oct 18, 2019	BUY	$3.42 - $5.35 $26,528 - $41,499	7,757 Added 6.56%	126,041 $572,000
Q1 2018 May 15, 2018	SELL	$3.42 - $5.35 $10,034 - $15,696	-2,934 Reduced 2.42%	118,284 $537,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.84 $25,496 - $37,853	-7,821 Reduced 6.06%	121,218 $482,000
Q3 2017 Nov 14, 2017	BUY	$3.83 - $4.89 $494,219 - $631,000	129,039	129,039 $569,000

Others Institutions Holding FBIO

# of Institutions

Shares Held

862K

Call Options Held

Put Options Held

View Full List

About Fortress Biotech, Inc.

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

More about FBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account